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WH2 (WASP homology 2) domain is a ubiquitous actin
monomer binding motif that is present in a wide variety of
regulators of the actin cytoskeleton. The article by John Ed-
wards presents an analysis suggesting that b-thymosins (in-
cluding proteins containing tandem b-thymosin-like repeats)
and other WH2 domains would not have a common ancestry.
As already pointed out in our review article [1], the WH2
domain is a very short protein motif and thus reliable phylo-
genetic analysis of this domain is diﬃcult. Thus, we agree that
it is not possible to conclude whether b-thymosins and other
WH2 domains have a common ancestor. However, all avail-
able biochemical and structural data indicate that b-thymosins
and other WH2 domains belong, from a structural and func-
tional point of view, to the same family of actin-binding
motifs.
Alignments of b-thymosins and other WH2 domains show
that their most highly conserved regions are the LKK motif
and region N-terminal of it. In contrast, the C-terminal regions
of b-thymosins display high sequence identity to each other,
whereas the C-terminal regions of other WH2 domains
are very heterogeneous [1,2]. Recent structural studies on
b-thymosin and ciboulot provide a plausible explanation for
the conservation of these sequence features. The most critical
actin-binding region is located in the LKK motif and in the
a-helical region preceding this motif. These regions interact
with the subdomains 1 and 3 at the ‘barbed-end’ of the actin
monomer. The highly conserved C-terminal region of
b-thymosins forms an additional a-helix, which interacts with
the subdomain 2 at the ‘pointed-end’ of actin monomer. This
C-terminal helix is present in actin ﬁlament sequestering
b-thymosins but it is absent from ciboulot, which promotes
actin ﬁlament assembly. Interestingly, b-thymosin can be
changed from an actin ﬁlament sequestering to assembly
promoting protein by disrupting this a-helix by site-directed
mutagenesis [3,4]. Together, these data provide a plausible
explanation for the lack of sequence conservation at the
C-terminal regions of those WH2 domains that do not display
actin monomer sequestering activity. Consequently, sequence
conservation between b-thymosins and other WH2 domains is
expected to be limited in the N-terminal actin-binding region.0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.06.099It is also important to note that b-thymosins and other WH2
domains have very similar actin-binding properties to each
other. All WH2 domains and b-thymosins tested so far bind
ATP-actin monomers with much higher aﬃnity than ADP-
actin monomers [5–7]. Furthermore, mutagenesis studies sug-
gest that b-thymosins and other WH2 domains interact with
actin through a similar interface, indicating that WH2 domain
is a structurally conserved actin-binding motif [6,8–10]. How-
ever, further structural analysis of other WH2 domain proteins
than b-thymosins and ciboulot will be required to reveal if b-
thymosins and other WH2 domains indeed interact with actin
through a conserved structural mechanism.
Based on these data, we suggest that from a structural and
functional point of view WH2 domains and b-thymosins most
likely belong to a single actin-binding motif family. However,
whether they have a common ancestry or if they are a result of
a convergence cannot be concluded at the moment. Reliable
phylogenetics of this actin-binding motif will thus require
identiﬁcation and analysis of a large number of new WH2
domains/b-thymosin family proteins.References
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